PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,244,000 | -23.0% | 26,071 | -14.5% | 0.01% | -46.2% |
| Q1 2016 | $1,616,000 | +7.2% | 30,500 | +55.4% | 0.01% | +160.0% |
| Q4 2015 | $1,507,000 | -62.7% | 19,633 | -80.0% | 0.01% | -76.2% |
| Q3 2015 | $4,038,000 | -24.4% | 98,245 | +30.1% | 0.02% | -34.4% |
| Q2 2015 | $5,340,000 | +271.1% | 75,515 | +366.1% | 0.03% | +190.9% |
| Q1 2015 | $1,439,000 | +78.3% | 16,200 | +40.5% | 0.01% | +83.3% |
| Q1 2014 | $807,000 | -66.0% | 11,534 | -76.6% | 0.01% | +20.0% |
| Q3 2013 | $2,372,000 | – | 49,336 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |